Evidence and Rationale for Antimicrobial Stewardship Standard in New R3 Report


A new “R3 Report” released by the Joint Commission addresses the correct use of antimicrobial medications to help combat resistance. It focuses on the Joint Commission’s new antimicrobial stewardship standard for accredited critical access hospitals, hospitals, and nursing care centers.  
The R3 Report provides a more in-depth rationale and evidence for the new standard that goes into effect on Jan. 1, 2017. According to information cited in the report, resistance to antimicrobial medications threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi.

The standard was developed to promote patient safety and quality of care, as well as to align critical-access hospital, hospital and nursing care center accreditation programs with current recommendations from professional and scientific organizations. The Joint Commission also plans to develop an antimicrobial stewardship standard for ambulatory and office-based surgery.

“This standard is based on current scientific literature and addresses the growing threat of antimicrobial-resistant organisms. It provides direction to hospital and nursing care center settings through requiring an antimicrobial stewardship program,” said Kelly Podgorny, DNP, CPHQ, RN, project director of the Division of Healthcare Quality Evaluation, the Joint Commission.

Antimicrobial/antibiotic stewardship is a proven method for improving the correct use of medications that treat infections, according to scientific and professional organizations. When implemented with organizational support, antimicrobial stewardship programs can help decrease the progression of antimicrobial resistance and improve how antimicrobials are used and prescribed.

The R3 Report is a periodic publication of the Joint Commission that provides details on the research and reference sources that informed the development of a standard.

The R3 Report may be viewed HERE

Source: The Joint Commission


Related Videos
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Related Content